Please join us on May 19, 2021 at 1:00 pm ET as Molly Simpson, Marketing Director, of Apollo Intelligence—parent company of InCrowd—present Oncology Biomarker Testing—Awareness, Drivers, and the Future.
The field of oncology biomarker testing is growing rapidly. With so many new cancer treatments available requiring specific biomarkers for prescription, oncologists have plenty of new information to follow and many decisions to make when treating individual tumors.
- Thoughts on how oncologists learn about new biomarker tests
- Views on what other education resources would be helpful
- Perspectives on oncology biomarker test choice and how these decisions are made
- Trends and changes in the kinds of tests being conducted, especially around tissue vs liquid testing in solid tumors